Crysvita - Burosumab
Active Ingredient: Burosumab
Manufacturer: Ultragenyx Pharmaceutical
Therapeutic area: Doenças Genéticas
Indication: Indicado no tratamento da hipofosfatemia
Dosage: 10mg/mL, 20mg/mL, and 30mg/mL
Size: Injection in single-dose vials
Temperature: Refrigerated